"Attitude is a little thing that makes a big difference" Winston Churchill

Gynecologic Oncology

Volumn 109, Issue 1, 2008, Pages 147-151

  Orr Jr , James W ^a   Naumann, Wendel R ^b   Escobar, Pedro ^c  

^a Florida Society of Gynecologic Oncologists   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c Gynecologic Oncology and Breast Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; CLINICAL TRIAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; HEALTH CARE COST; HUMAN; LAPAROSCOPIC SURGERY; LETTER; LYMPH NODE DISSECTION; LYMPHADENECTOMY; METASTASIS; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; TELETHERAPY; TREATMENT PLANNING;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING;

EID: 40949142535     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.12.011     Document Type: Letter

References (48)

1. Aalders J.G., and Thomas G. Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 104 1 (2007) 222-231
2. Orr J.W. Surgical staging of endometrial cancer: does the patient benefit?. Gynecol. Oncol. 71 3 (1998) 335-339
3. Arduino S., et al. Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer. Eur. J. Gynaecol. Oncol. 18 3 (1997) 208-210
4. Babilonti L., et al. Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. Eur. J. Gynaecol. Oncol. 10 2 (1989) 131-133
5. Giannice R., et al. Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer 92 10 (2001) 2562-2568
6. Homesley H.D. Revised 1988 International Federation of Gynecology and Obstetrics staging systems for endometrial and vulvar cancer: an assessment. Clin. Obstet. Gynecol. 35 1 (1992) 89-94
7. Larson D.M., Johnson K., and Olson K.A. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet. Gynecol. 79 6 (1992) 998-1001
8. Clarke-Pearson D.L., et al. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet. Gynecol. 101 1 (2003) 157-163
9. Walker J., et al. Phase III trial of laparoscopy versus laparotomy for surgicalresection and comprehensive surgical staging of uterine cancer: A Gynecologic Oncology Group study funded by the National Cancer Institute. Gynecol. Oncol. 101 S1 (2006) S11-S12
10. Onda T., et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br. J. Cancer 75 12 (1997) 1836-1841
11. Corn B.W., et al. Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. Int. J. Radiat Oncol. Biol. Phys. 24 2 (1992) 223-227
12. Rose P.G., et al. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 24 2 (1992) 229-233
13. Morrow C.P., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40 1 (1991) 55-65
14. Geisler J.P., Wiemann M.C., and Manahan K.J. When should pelvic and para-aortic lymphadenectomy be performed in patients with endometrioid adenocarcinoma of the endometrium?. Gynecol. Oncol. 1996 3 (2005) 917-918
15. Barakat R.R., et al. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol. Oncol. 105 1 (2007) 150-156
16. Takeshima N., et al. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet. Gynecol. 88 2 (1996) 280-282
17. Naumann R.W., and Coleman R.L. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. Gynecol. Oncol. 105 1 (2007) 7-12
18. Frumovitz M., et al. Predictors of final histology in patients with endometrial cancer. Gynecol. Oncol. 95 3 (2004) 463-468
19. Frumovitz M., et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J. Am. Coll Surg 199 3 (2004) 388-393
20. Goff B.A., and Rice R. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol. Oncol. 38 1 (1990) 46-48
21. Traen K., Holund B., and Mogensen O. Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta. Obstet. Gynecol. Scand. 86 6 (2007) 739-741
22. Girardi F., et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol. Oncol. 49 2 (1993) 177-180
23. Arango H.A., et al. Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet. Gynecol. 95 4 (2000) 553-556
24. Case A.S., et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet. Gynecol. 108 6 (2006) 1375-1379
25. Briet J.M., et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol. Oncol. 96 3 (2005) 799-804
26. Creasman W.T., et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 8 Suppl (1987) 2035-2041
27. Gemer O., et al. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. Eur. J. Surg. Oncol. 33 5 (2007) 644-647
28. Ben-Shachar I., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet. Gynecol. 105 3 (2005) 487-493
29. Kilgore L.C., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56 1 (1995) 29-33
30. Chan J.K., et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107 8 (2006) 1823-1830
31. Mariani A., et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol. Oncol. 101 2 (2006) 200-208
32. Bristow R.E., et al. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer 13 5 (2003) 664-672
33. Havrilesky L.J., et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol. Oncol. 99 3 (2005) 689-695
34. Chan J.K., et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients. Br. J. Cancer 96 12 (2007) 1817-1822
35. Lutman C.V., et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 102 1 (2006) 92-97
36. Kitcher H. ASTEC - a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol. 101 S1 (2006) S21-S22
37. Kong A., et al. Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann. Oncol. 18 10 (2007) 1595-1604
38. Orr J.W., Holimon J.L., and Orr P.F. Stage I corpus cancer: is teletherapy necessary?. Am. J. Obstet Gynecol. 176 4 (1997) 777-788 discussion 788-9.
39. Straughn J.M., et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol. Oncol. 89 2 (2003) 295-300
40. Small W., Erickson B., and Kwakwa F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 63 5 (2005) 1502-1507
41. Barnes M.N., et al. A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol. Oncol. 74 3 (1999) 443-447
42. Fanning J. Treatment for early endometrial cancer. Cost-effectiveness analysis. J. Reprod. Med. 44 8 (1999) 719-723
43. Fanning J., et al. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Gynecol. Oncol. 93 3 (2004) 632-636
44. Konski A.A., et al. Cost minimization analysis of various treatment options for surgical stage I endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 37 2 (1997) 367-373
45. Kwon J.S., et al. Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer. J. Obstet. Gynaecol. Can. 29 2 (2007) 131-139
46. Rankins N.C., et al. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer. Gynecol. Oncol. (2007)
47. Alektiar K.M. In response to: Intravaginal brachytherapy alone for intermediate-Risk endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys. 63 4 (2005) 1275
48. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet. Gynecol. 106 2 (2005) 413-425